Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis

Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis

Abstract Background Abatacept (ABA) is a biological disease-modifying antirheumatic drug (bDMARD) for rheumatoid arthritis (RA). The aim of this study was to identify molecules that are associated with therapeutic responses to ABA in patients with RA. Methods Peripheral blood was collected using a P...

Full description

Bibliographic Details
Main Authors: Waka Yokoyama-Kokuryo, Hayato Yamazaki, Tsutomu Takeuchi, Koichi Amano, Jun Kikuchi, Tsuneo Kondo, Seiji Nakamura, Ryoko Sakai, Fumio Hirano, Toshihiro Nanki, Ryuji Koike, Masayoshi Harigai
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Arthritis Research & Therapy
Subjects:
Rheumatoid arthritis
Abatacept
Prediction
Microarray
Interferon signature
Online Access:http://link.springer.com/article/10.1186/s13075-020-2137-y

Internet

http://link.springer.com/article/10.1186/s13075-020-2137-y

Similar Items